Jingxin Liu

Jingxin Liu

Auto-generated profile, based on publicly available information

Jingxin Liu

Department of Radiology, China-Japan Union Hospital of Jilin University, Changchun, CO 130033 China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2020 in IEEE Access
Verified
Journal Article
Open access
HLHuiying Li
Huiying Li
XZXiaoqing Zhao
Xiaoqing Zhao
ASAnyang Su
Anyang Su
HZHaitao Zhang
Haitao Zhang
JLJingxin Liu
Jingxin Liu
GGGuiying Gu
Guiying Gu
White blood cells (WBCs) are the cells of immune system, protecting against infective diseases and invasion of viruses and bacteria. Their aberrant number, both abnormal increase and decrease, is a sign of an ongoing pathology, a precise evaluation of their number is of the utmost importance as the first step of assessing a potential disease. In blood cell microscopic images, since red blood cells and platelets are similar in color with WBCs, and WBCs are partially adhesive, WBC segmentation for counting is often not resulting in a good performance. Therefore, in this work, a color space transformation is proposed to filter out red blood cells and platelets, which is transforming the blood cell microscopic images of patients with acute lymphoblastic leukemia from RGB color space to HSV to detect and extract WBCs. For precisely segmenting adhesive WBCs in extraction results, we set cell border to the third class, in addition to foreground and background. A weighted cross-entropy loss function based on class weight and distance transformation weight enhanced U-Net to learn cell border features. Our results showed that the method proposed in this paper for WBC segmentation using the data set ALL_IDB1 could achieve an accuracy of 97.92%.

1 May 2019 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
JLJingxin Liu
Jingxin Liu
ZSZhangzhen Shi
Zhangzhen Shi
YBYuansong Bai
Yuansong Bai
LLLin Liu
Lin Liu
KCKailiang Cheng
Kailiang Cheng
Introduction: The prognostic significance of the systemic immune-inflammation index (SII) in breast cancer is unknown. Here, we aimed to explore the connection between pretreatment SII and the survival of patients with triple-negative breast cancer (TNBC). Methods: We enrolled 160 TNBC patients treated in our hospital between May 2000 and June 2012. We employed the Kaplan-Meier curve and log-rank test to assess overall survival (OS), disease-free survival (DFS), and distant metastasis-free survival (DMFS). We identified the prognostic significance of SII using the Cox regression model. Results: The Kaplan-Meier curve revealed the median OS as 44.2 and 82.4 months in high and low SII TNBC patients, respectively (P<0.001). According to univariate and multivariate analyses, increased SII correlated with poor OS (HR =2.91, 95% CI: 2.00–4.23, P<0.001; HR =2.60, 95% CI: 1.74–3.88, P<0.001). The DFS and DMFS of patients with high SII were 18.8 and 23.8 months, respectively, while those of patients with low SII were 29 and 45.2 months, respectively, (P<0.001). Further univariate analyses showed a significant correlation between SII and DFS and DMFS (P<0.01), while results from multivariate analyses suggested that SII is an independent prognostic factor for DFS (P=0.045), but not for DMFS (P=0.078). The area under the receiver operating characteristics curves for SII to differentiate between long and short OS, DFS, and DMFS were 0.69, 0.60, and 0.64, respectively. Conclusion: Our findings may point to SII having an independent prognostic significance in TNBC patients. Prospective in-depth studies, using a larger sample size, are required to further investigate the precise role of SII in TNBC before clinical use.